Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Azienda Ospedaliero-Universitaria di Parma
A2 Biotherapeutics Inc.
IDEAYA Biosciences
CRISPR Therapeutics
7 Hills Pharma, LLC
Nurix Therapeutics, Inc.
Numab Therapeutics AG
NuCana plc
Telix Pharmaceuticals (Innovations) Pty Limited
Medicenna Therapeutics, Inc.
Cancer Research UK
Novartis
Memorial Sloan Kettering Cancer Center
University Hospital, Antwerp
Checkpoint Therapeutics, Inc.
University Hospital, Antwerp
Ipsen
Mabpro, a.s.
Jules Bordet Institute
Institut Bergonié
Quadriga Biosciences, Inc.
Augusta University
Memorial Sloan Kettering Cancer Center
Abramson Cancer Center at Penn Medicine
Fox Chase Cancer Center
Swiss Cancer Institute
Kantonsspital Winterthur KSW
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)